Renal dysfunction after chronic blockade of nitric oxide synthesis

Antioxidants and Redox Signaling

Volumn 4, Issue 6, 2002, Pages 885-891

  Cachofeiro, Victoria ^a   Fortepiani, Lourdes A ^b   Navarro Cid, Josefa ^a   Lahera, Vicente ^a   García Estañ, Joaquín ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADRENALIN; ALDOSTERONE; ENDOTHELIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITE; NORADRENALIN; RENIN; THROMBOXANE A2; THROMBOXANE B2;

ADRENALIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIURESIS; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY TUBULE FUNCTION; MALE; NATRIURESIS; NONHUMAN; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYNTHESIS; URINARY EXCRETION;

ANIMALIA; GLOMERULUS;

EID: 12244261624     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308602762197425     Document Type: Article

References (34)

1. Arcos MI, Fujihara CK, Sesso A, de Almeida Prado EB, de Almeida Prado MJ, de Nucci G and Zatz R. Mechanisms of albuminuria in the chronic nitric oxide inhibition model. Am J Physiol 279: F1060-F1066, 2000.
2. Barnes RD, Ward LE, Frank KP, Tyce GM, Hunter LW, and Rorie DK. Nitric oxide modulates evoked catecholamine release from canine adrenal medulla. Neuroscience 104: 1165-1173, 2001.
3. Beierwaltes WH and Carretero OA. Nonprostanoid endothelium-derived factors inhibit renin release. Hypertension 19 (Suppl):II68-II73, 1992.
4. D'Amours M, Lebel M, Grose JH, and Lariviere R. Renal and vascular effects of chronic nitric oxide synthase inhibition: Involvement of endothelin 1 and angiotensin II. Can J Physiol Pharmacol 77: 8-16, 1999.
5. Edwards RM and Trizna W. Modulation of glomerular arteriolar tone by nitric oxide synthase inhibitors. J Am Soc Nephrol 4: 1127-1132, 1993.
6. Fortepiani LA, Rodrigo E, Ortíz MC, Cachofeiro V, Atucha NM, Ruilope LM, Lahera V, and García-Estañ J. Pressure natriuresis in nitric oxide-deficient hypertensive rats: Effect of antihypertensive treatments. J Am Soc Nephrol 10: 21-27, 1999.
7. García-Estañ J, Navarro J, Atucha NM, Quesada T, Romero JC, Cachofeiro V, and Lahera V. Chronic effect of nitric oxide and prostaglandin inhibition on pressure diuresis and natriuresis in rats. Kidney Int 49: S141-S143, 1996.
8. Guarasci GR and Kline RL. Pressure natriuresis following acute and chronic inhibition of nitric oxide synthase in rats. Am J Physiol 270: R469-R478, 1996.
9. Hanke CJ, Drewett JG, Myers CR, and Campbell WB. Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect. Endocrinology 139: 4053-4060, 1998.
10. Harrison-Bernard LM, Albert DF, and Cook AK. Nitric modulation of outer medullary descending vasa recta diameter. (Abstract). FASEB J 13: A720, 1999.
11. Hertzan-Levy S, Fish R, Skutelsky E, Wollman Y, Chernichovsky T, Polak-Charcon S, Schwartz D, Blum M, Cabili S, and Iaina A. Glomerular basement membrane anionic sites in adriamycin nephropathy: Effect of saline loading and nitric oxide modulation. Nephron 84: 354-361, 2000.
12. Imig JD and Roman RJ. Nitric oxide modulates vascular tone in preglomerular arterioles. Hypertension 19: 770-774, 1992.
13. Kadekaro M, Terrell ML, Harmann P, and Summy-Long JY. Central inhibition of nitric oxide synthase attenuates water intake but does not alter enhanced glucose utilization in the hypothalamo-neurohypohysis system of dehydrated rats. Neurosci Lett 173: 115-118, 1994.
14. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol 261: F1033-F1037, 1991.
15. Lahera V, Navarro-Cid J, Cachofeiro V, García-Estañ J, and Ruilope LM. Nitric oxide, the kidney, and hypertension. Am J Hypertens 10: 129-140, 1997.
16. Manning RD, Hu L, and Reckelhoff JF. Role of nitric oxide in the arterial pressure and renal adaptations to long-term changes in sodium intake. Am J Physiol 272: R1162-R1169, 1997.
17. Matsumura K, Abe I, Tsuchihashi T, and Fujishima M. Central nitric oxide attenuates the baroreceptor reflex in conscious rabbits. Am J Physiol 274: R1142-R1149, 1998.
18. Moncada S. Nitric oxide in the vasculature: Physiology and pathophysiology. Ann N Y Acad Sci 811: 60-67, 1997.
19. Navarro J, Sánchez A, Sáiz J, Ruilope LM, García-Estañ J, Romero JC, Moncada S, and Lahera V. Hormonal, renal and metabolic alterations during the hypertension induced by chronic inhibition of nitric oxide in rats. Am J Physiol 267: R1516-R1521, 1994.
20. Navarro-Cid J, Maeso R, Rodrigo E, Muñoz-García R, Ruilope LM, Lahera V, and Cachofeiro V. Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs. Am J Hypertens 9: 1077-1083, 1996.
21. Pollock DM. Chronic studies on the interaction between nitric oxide and endothelin in cardiovasular and renal function. Clin Exp Pharmacol Physiol 26: 258-261, 1999.
22. Pollock DM, Polakowski JS, Divish BJ, and Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 21: 660-666, 1993.
23. Qiu C, Muchant D, Beierwaltes WH, Racusen L, and Baylis C. Evolution of chronic nitric oxide inhibition hypertension: Relationship to renal function. Hypertension 31: 21-26, 1998.
24. Raber J and Bloom FE. IL-2 induces vasopressin release from the hypothalamus and the amygdala: Role of nitric oxide-mediated signalling. J Neurosci 14: 115-118, 1994.
25. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, and Zatz R: Chronic inhibition of nitric oxide synthesis, a new model of arterial hypertension. Hypertension 20: 298-303, 1992.
26. Sakuma IH, Togashi H, Yoshioka M, Saito H, Yanagida M, Tamura M, Kobayashi T, Yasuda H, Gross S, and Levi R. NO-Methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. Circ Res 70: 607-611, 1992.
27. Salemi R, McDougall JG, Hardy KJ, and Wintour EM. Local inhibition of nitric oxide temporarily stimulates aldosterone secretion in conscious sheep in vivo. Am J Physiol 280: E584-E590, 2001.
28. Schmidt A, Bayerle-Eder M, Pleiner H, Zeisner C, Wolzt M, and Schmetterer L. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men. Nitric Oxide 5: 370-376, 2001.
29. Schnackenberg CG, Tabor BL, Strong MH, and Granger JP. Inhibition of intrarenal NO stimulates renin secretion through a macula densa-mediated mechanism. Am J Physiol 272: R879-R886, 1997.
30. Tassorelli C, Costa A, Blandini F, Joseph SA, and Nappi G. Effect of nitric oxide donors on the central nervous system. Nitroglycerin studies in the rat. Funct Neurol 15 (Suppl 3): 19-27, 2000.
31. Toda N, Kitamura Y, and Okamura T. Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension 21: 3-8, 1993.
32. Wagner C and Kurtz A. Regulation of renal renin release. Curr Opin Nephrol Hypertens 7: 437-441, 1998.
33. Ziche M and Morbidelli L. Nitric oxide and angiogenesis. J Neurooncol 50: 139-148, 2000.
34. Zou AP and Cowley A. Role of nitric oxide in the control of renal function and salt sensitivity. Curr Hypertens Rep 2: 178-186, 1999.